Abstract:The gut microbiota has been shown to be associated with a range of illnesses and disorders, including hypertension, which is recognized as the primary factor contributing to the development of serious cardiovascular diseases. In this review, we conducted a comprehensive analysis of the progression of the research domain pertaining to gut microbiota and hypertension. Our primary emphasis was on the interplay between gut microbiota and blood pressure that are mediated by host and gut microbiota-derived metabolites. Additionally, we elaborate the reciprocal communication between gut microbiota and antihypertensive drugs, and its influence on the blood pressure of the host. The field of computer science has seen rapid progress with its great potential in the application in biomedical sciences, we prompt an exploration of the use of microbiome databases and artificial intelligence in the realm of high blood pressure prediction and prevention. We propose the use of gut microbiota as potential biomarkers in the context of hypertension prevention and therapy.

What problem does this paper attempt to address?

The main issue this paper attempts to address is the exploration of the untapped potential of the gut microbiome in hypertension management. Specifically, the paper emphasizes the interaction between host and gut microbiome-derived metabolites in regulating blood pressure through a comprehensive analysis of the relationship between the gut microbiome and hypertension. Additionally, the paper explores the mutual influence between the gut microbiome and antihypertensive drugs, and how this influence affects the host's blood pressure. The paper proposes utilizing the gut microbiome as potential biomarkers for the prevention and treatment of hypertension and discusses the potential application of microbiome databases and artificial intelligence in hypertension prediction and prevention. ### Main Research Content: 1. **Characteristics of the Gut Microbiome**: Introduces the composition of the gut microbiome in healthy individuals and its impact on host health. 2. **Relationship Between Hypertension and the Gut Microbiome**: Discusses changes in the gut microbiome of hypertensive patients, including reduced microbial diversity and increased specific microbial populations. 3. **Mechanisms of Gut Microbial Metabolites and Hypertension**: - **Short-Chain Fatty Acids (SCFAs)**: SCFAs regulate blood pressure through various pathways, including activating G protein-coupled receptors (GPCRs) and reducing vascular tension. - **Trimethylamine N-oxide (TMAO)**: TMAO is associated with an increased risk of hypertension and may affect blood pressure by enhancing the hypertensive effects of angiotensin II. - **Bile Acids (BAs)**: BAs lower blood pressure by activating multiple receptors such as TGR5 and FXR. - **Hydrogen Sulfide (H2S)**: H2S lowers blood pressure by dilating peripheral blood vessels and improving endothelial function. - **5-Hydroxytryptamine (5-HT)**: The role of 5-HT in hypertension is complex; it can cause vasoconstriction by stimulating the vagus nerve or lower blood pressure by binding to different receptors. 4. **Impact of Gut Microbiota Dysbiosis Induced by High-Salt Diet on Hypertension**: A high-salt diet alters the composition of the gut microbiome, promoting inflammatory responses and the development of hypertension. 5. **Application of Gut Microbiota Interventions in Hypertension Treatment**: Discusses the interaction between the gut microbiome and major antihypertensive drugs (such as calcium channel blockers, ACE inhibitors, ARBs, diuretics, and β-blockers), and how these drugs affect the structure and metabolic capacity of the gut microbiome. ### Conclusion: The paper proposes utilizing the gut microbiome as potential biomarkers for the prevention and treatment of hypertension and explores the application prospects of computer science and artificial intelligence in this field. By gaining a deeper understanding of the complex relationship between the gut microbiome and hypertension, new strategies and methods for the management and treatment of hypertension can be provided.

Untapped potential of gut microbiome for hypertension management

Gut microbiota and hypertension: association, mechanisms and treatment

Gut microbiota: a potential new regulator of hypertension

Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review

The gut microbiome and hypertension

Gut microbiota dysbiosis contributes to the development of hypertension

Influence of Dietary Components and Traditional Chinese Medicine on Hypertension: A Potential Role for Gut Microbiota

Microbial Peer Pressure: The Role of the Gut Microbiota in Hypertension and Its Complications

The Role and Mechanism of Intestinal Flora in Blood Pressure Regulation and Hypertension Development

Research Progress on the Correlation Between Hypertension and Gut Microbiota

The Role of Gut Microbiota in Hypertension Pathogenesis and the Efficacy of Antihypertensive Drugs

Gut microbial metabolic flux disorder in hypertension

Gastrointestinal Tract: a Promising Target for the Management of Hypertension

Microbial influence on blood pressure: unraveling the complex relationship for health insights

Unique intestinal microflora and metabolic profile in different stages of hypertension reveal potential biomarkers for early diagnosis and prognosis

Targeting intestinal microecology: potential intervention strategies of traditional Chinese medicine for managing hypertension

Gut Microbiota Dysbiosis In Human Hypertension: A Systematic Review Of Observational Studies

Combating hypertension beyond genome-wide association studies: Microbiome and artificial intelligence as opportunities for precision medicine

The Role of Short-Chain Fatty Acids of Gut Microbiota Origin in Hypertension

The Microbiome and Blood Pressure: Can Microbes Regulate Our Blood Pressure?

Gut microbiota-derived short-chain fatty acids and hypertension: Mechanism and treatment